{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:06Z","timestamp":1793600826406,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["NKI 2006\\u20134176"],"award-info":[{"award-number":["NKI 2006\\u20134176"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ygyno.2026.03.011","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T14:43:42Z","timestamp":1774709022000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Influence of cardiophrenic lymph nodes on survival in patients receiving hyperthermic intraperitoneal chemotherapy for ovarian cancer in the OVHIPEC-1 trial"],"prefix":"10.1016","volume":"208","author":[{"given":"Madelief","family":"Schreuder Goedheijt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Lot","family":"Aronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabe S.","family":"Sonke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willemien J.","family":"van Driel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Lopez-Yurda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margriet C.","family":"van Dijk - de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max J.","family":"Lahaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2026.03.011_bb0005","author":"Surveillance E, and End Results Program"},{"key":"10.1016\/j.ygyno.2026.03.011_bb0010","article-title":"Clinical significance of enlarged cardiophrenic lymph nodes by CT in advanced ovarian cancer","volume":"13","author":"Song","year":"2023","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2026.03.011_bb0015","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/aogs.13835","article-title":"Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer","volume":"99","author":"Luger","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"1","key":"10.1016\/j.ygyno.2026.03.011_bb0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2018.11.001","article-title":"Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer","volume":"152","author":"Prader","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2026.03.011_bb0025","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00261-017-1158-8","article-title":"Prognostic significance of supradiaphragmatic lymph nodes at initial presentation in patients with stage III high-grade serous ovarian cancer","volume":"42","author":"McIntosh","year":"2017","journal-title":"Abdom. Radiol. (NY)"},{"issue":"9","key":"10.1016\/j.ygyno.2026.03.011_bb0030","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0009-9260(97)80034-7","article-title":"The significance of paracardiac lymph node enlargement in ovarian cancer","volume":"52","author":"Holloway","year":"1997","journal-title":"Clin. Radiol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.03.011_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.ygyno.2026.03.011_bb0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2012.04.023","article-title":"FDG PET\/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread","volume":"126","author":"Hynninen","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.03.011_bb0045","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1186\/s12885-018-5067-1","article-title":"Prognostic significance of supradiaphragmatic lymph node metastasis detected by (18)F-FDG PET\/CT in advanced epithelial ovarian cancer","volume":"18","author":"Lee","year":"2018","journal-title":"BMC Cancer"},{"issue":"19","key":"10.1016\/j.ygyno.2026.03.011_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13195017","article-title":"Survival in advanced-stage epithelial ovarian cancer patients with cardiophrenic lymphadenopathy who underwent cytoreductive surgery: a systematic review and meta-analysis","volume":"13","author":"Kengsakul","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ygyno.2026.03.011_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00261-020-02618-z","article-title":"Clinical significance of CT detected enlarged cardiophrenic nodes in ovarian cancer patients","volume":"46","author":"Oommen","year":"2021","journal-title":"Abdom. Radiol. (NY)"},{"issue":"1","key":"10.1016\/j.ygyno.2026.03.011_bb0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2017.10.024","article-title":"Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: implications for survival","volume":"148","author":"Mert","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.03.011_bb0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ygyno.2015.05.007","article-title":"The significance of paracardiac lymph-node enlargement in patients with newly diagnosed stage IIIC ovarian cancer","volume":"138","author":"Raban","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2026.03.011_bb0070","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.ejso.2022.06.006","article-title":"What are the implications of radiologically abnormal cardiophrenic lymph nodes in advanced ovarian cancer? An analysis of tumour burden, surgical complexity, same-site recurrence and overall survival","volume":"48","author":"Addley","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.03.011_bb0075","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1186\/s12905-022-02082-5","article-title":"Upfront surgery in patients with epithelial ovarian cancer and enlarged supradiaphragmatic lymph nodes associated with comparable to neoadjuvant chemotherapy","volume":"22","author":"Weitzner","year":"2022","journal-title":"BMC Womens Health"},{"issue":"6","key":"10.1016\/j.ygyno.2026.03.011_bb0080","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/IGC.0b013e3181e833f5","article-title":"Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer","volume":"20","author":"Kolev","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2026.03.011_bb0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13048-020-00625-8","article-title":"Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters","volume":"13","author":"Sartor","year":"2020","journal-title":"J. Ovarian Res."},{"issue":"10","key":"10.1016\/j.ygyno.2026.03.011_bb0090","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.21873\/anticanres.15317","article-title":"Role of the cardiophrenic lymph node status after neoadjuvant chemotherapy in primary advanced ovarian cancer","volume":"41","author":"Luengas-Wuerzinger","year":"2021","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.ygyno.2026.03.011_bb0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/0284186X.2023.2204993","article-title":"Radiologically enlarged cardiophrenic lymph nodes and CA-125 in relation to diaphragmatic carcinomatosis, surgical outcome, and overall survival in advanced ovarian cancer","volume":"62","author":"Plana","year":"2023","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ygyno.2026.03.011_bb0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.gore.2019.03.008","article-title":"Isolated distant lymph node metastases in ovarian cancer. Should a new substage be created?","volume":"28","author":"Nasioudis","year":"2019","journal-title":"Gynecol. Oncol. Rep."},{"issue":"7","key":"10.1016\/j.ygyno.2026.03.011_bb0105","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1007\/s00330-024-11300-7","article-title":"Ovarian cancer staging and follow-up: updated guidelines from the European Society of Urogenital Radiology female pelvic imaging working group","volume":"35","author":"Rizzo","year":"2025","journal-title":"Eur. Radiol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.03.011_bb0110","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2026.03.011_bb0115","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ygyno.2026.03.011_bb0120","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1470-2045(23)00396-0","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial","volume":"24","author":"Aronson","year":"2023","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2026.03.011_bb0125","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1007\/s00330-020-07572-4","article-title":"Introducing the node reporting and data system 1.0 (node-RADS): a concept for standardized assessment of lymph nodes in cancer","volume":"31","author":"Elsholtz","year":"2021","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ygyno.2026.03.011_bb0130","series-title":"R: A Language and Environment for Statistical Computing","author":"Team. RC","year":"2009"},{"issue":"12","key":"10.1016\/j.ygyno.2026.03.011_bb0165","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1136\/ijgc-2020-001825","article-title":"Central radiology assessment of the randomized phase III open-label OVHIPEC-1 trial in ovarian cancer","volume":"30","author":"Koole","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2026.03.011_bb0140","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/ijgc-2023-004963","article-title":"Cardiophrenic lymph nodes in advanced ovarian cancer","volume":"34","author":"Agusti","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2026.03.011_bb0145","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1245\/s10434-015-5015-0","article-title":"Preoperative prediction of cardiophrenic lymph node metastasis in advanced ovarian cancer using computed tomography","volume":"23","author":"Kim","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.03.011_bb0170","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/0284186X.2017.1400691","article-title":"Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish gynecologic cancer group (SweGCG) study","volume":"57","author":"Hjerpe","year":"2018","journal-title":"Acta Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.03.011_bb0175","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/ijgc-2018-000100","article-title":"Localization of distant metastases defines prognosis and treatment efficacy in patients with FIGO stage IV ovarian cancer","volume":"29","author":"Timmermans","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2026.03.011_bb0180","first-page":"1","article-title":"Characteristics of long-term survival in advanced stage ovarian cancer: a nationwide cohort in the Netherlands","volume":"43","author":"Wagensveld","year":"2022","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.03.011_bb0185","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ygyno.2018.06.022","article-title":"Sites of distant metastases and overall survival in ovarian cancer: a study of 1481 patients","volume":"150","author":"Deng","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2026.03.011_bb0190","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ygyno.2026.03.011_bb0195","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/ijgc-2019-000981","article-title":"Recurrence patterns in patients with abnormal cardiophrenic lymph nodes at ovarian cancer diagnosis","volume":"30","author":"Larish","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2026.03.011_bb0200","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ygyno.2020.03.003","article-title":"Prognostic value of radiological recurrence patterns in ovarian cancer","volume":"157","author":"Roze","year":"2020","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582601930X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582601930X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:34:40Z","timestamp":1793597680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582601930X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"alternative-id":["S009082582601930X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.03.011","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of cardiophrenic lymph nodes on survival in patients receiving hyperthermic intraperitoneal chemotherapy for ovarian cancer in the OVHIPEC-1 trial","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}